Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
18°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
General
RHHVF
RHHBF
From
Benzinga
WHO Recommends Against Roche, GSK's COVID-19 Therapies Rendering Them Obsolete
September 16, 2022
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
News
Health Care
GSK
From
Benzinga
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
September 13, 2022
Tickers
NVS
OTLK
REGN
RHHBY
Tags
News
Penny Stocks
Trading Ideas
From
Benzinga
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
September 12, 2022
Tickers
ABML
ADDYY
BASFY
BFFAF
Tags
ADDYY
IFNNY
FMCC
From
Benzinga
Why Regeneron Pharmaceuticals Stock Is Crushing It Today
September 08, 2022
Tickers
BAYN
REGN
RHHBY
Tags
RHHBY
REGN
BAYN
From
Motley Fool
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
Tickers
A
ABT
BDX
BRKR
Tags
BRKR
Top Stories
HOLX
From
Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
Tickers
ESALF
ESALY
LLY
RHHBF
Tags
ESALF
Health Care
LLY
From
Benzinga
China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche's Genentech
August 18, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Contracts
Market News
From
Benzinga
Roche's Polivy Combo Regime Under FDA Review For Type Of Blood Cancer
August 16, 2022
Tickers
RHHBF
RHHBY
RHHVF
SGEN
Tags
FDA
RHHBF
RHHVF
From
Benzinga
OTC Markets' Most Active Securities Sees A Shake-up In July
August 16, 2022
Tickers
ADDYY
AYRWF
BASFY
BMIX
Tags
CYDY
Partner Content
ZURVY
From
Benzinga
FDA Approves Expanded Use Of Roche's Influenza Treatment
August 12, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Market News
News
From
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Tickers
ADMP
AEMD
ALPN
ARDS
Tags
Offerings
ADMP
CNTA
From
Benzinga
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
August 08, 2022
Tickers
AMGN
MRK
RHHBF
RHHBY
Tags
News
Large Cap
AMGN
From
Benzinga
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
August 05, 2022
Tickers
ADDYY
BASFY
BNPQY
BTC
Tags
Small Cap
financial stocks
$BTC
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
IBB
FDA
RIGL
From
Benzinga
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
August 03, 2022
Tickers
KNSA
RHHBY
Tags
Briefs
Benzinga
Movers
From
Benzinga
Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field
August 03, 2022
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
why it's moving
Contracts
RHHBY
From
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Tickers
ABBV
ACIU
ALLR
AXLA
Tags
SAGE
ALLR
NAUT
From
Benzinga
How This Multibillion-Dollar Company Is Shaking Off the Competition
July 30, 2022
Tickers
CHGCY
REGN
RHHBY
Tags
Recent Press Releases
Market News
CHGCY
From
Motley Fool
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
IBB
Legal
FDA
From
Benzinga
Why Shares of Agenus Inc. Rose 10.1% on Tuesday
July 26, 2022
Tickers
AGEN
RHHBY
Tags
Recent Press Releases
AGEN
Market News
From
Motley Fool
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
July 25, 2022
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
RHHVF
General
RHHBF
From
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Tickers
ABBV
ABUS
ASMB
HLVX
Tags
HLVX
Health Care
Penny Stocks
From
Benzinga
Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21
July 21, 2022
Tickers
AAPL
AMZN
BIDU
BIIB
Tags
COIN
BLK
NOK
From
Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
July 21, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
Biotech
Benzinga
From
Benzinga
Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz
July 19, 2022
Tickers
NVS
RHHBY
Tags
General
Benzinga
Biotech
From
Benzinga
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
July 18, 2022
Tickers
ADDYY
AERG
AXAHY
BNPQY
Tags
BNPQY
TSCDY
Benzinga
From
Benzinga
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test
July 18, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
Health Care
From
Benzinga
New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A
July 11, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Market News
News
From
Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
July 11, 2022
Tickers
BIOVF
CANF
IBB
INVA
Tags
M&A
MGNX
INVA
From
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.